Jutarnji list - #zatajenje bubrega

Editorial use only
Patient holding a box of Semaglutide diabetes medication. Marketed as Ozempic, this is a GLP-1 analogue that is used to treat diabetes and is used for weight management. It binds to the GLP-1 receptor and increases insulin secretion, suppresses glucagon secretion as well as slowing gastric emptying. Ozempic is administered by injection into the thigh, abdomen or upper arm.,Image: 705407177, License: Rights-managed, Restrictions: Editorial use only Model Released, Model Release: yes, Credit line: DR P. MARAZZI/Sciencephoto/Profimedia

LIJEK ZA DIJABETES Ispitivanje lijeka prekinuli godinu dana ranije: Prve analize pokazale da Ozempic uspješno liječi zatajenje bubrega 11.10.2023. u 06:32

Učitaj više